Submitted by Anonymous (not verified) on 19 October 2026 - 12:38
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised